Post-approval studies (Phase 4)Study completedNCT02417935
What this trial is testing
Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
Who this might be right for
Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company 304